Clinical features and outcomes of patients with non-erythrodermic mycosis fungoides with high blood tumor burden
Open Access
- 25 April 2026
- journal article
- Published by Elsevier in Blood Neoplasia
- Vol. 3 (3) , 100239
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Insights into Nodal T-Follicular Helper Cell lymphomas and Peripheral T-Cell Lymphomas, Not Otherwise Specified, in Slovenian Patients: Mutational Landscape, Clinicopathological Characteristics, and OutcomesAnnals of Hematology, 2025
- Blood classification and blood response criteria in mycosis fungoides and Sézary syndrome using flow cytometry: recommendations from the EORTC cutaneous lymphoma task forceEuropean Journal of Cancer, 2018
- Sézary syndrome without erythroderma: A review of 16 cases at Mayo ClinicJournal of the American Academy of Dermatology, 2017
- Sézary syndrome without erythrodermaJournal of the American Academy of Dermatology, 2015
- Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomasNature Genetics, 2014
- Long-term Outcomes of 1,263 Patients with Mycosis Fungoides and Sézary Syndrome from 1982 to 2009Clinical Cancer Research, 2012
- Sézary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviorsBlood, 2010
- Mycosis fungoides and Sézary syndromeThe Lancet, 2008
- Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)Blood, 2007
- WHO-EORTC classification for cutaneous lymphomasBlood, 2005